10.1002/jor.22133 44 JuY.HuY.YangP.XieX.FangB
While in the case of of semaglutide mutant 524 (supplementary file 4452.pdb ) here, one clear cut interfacial salt bridge was formed at 3.122 (Table 4) between Arg127 (Arg36 in Figure 1, B ARG 36 in 4ZGM [29, 52]) and Glu40 of GLP-1R ECD (A GLU 68 in 4ZGM [29, 52]), and another one also categorized here as an interfacial salt bridge at 4.023 , as the inter-actomic distance (4.023 , Table 4) is almost the cut-off distance (4.0 ) for salt bridge analysis as used in [50]
The same 7 hacks work for both medications.
Retatrutide showed superior improvements in multiple cardiometabolic markers: HbA1c reduction: Up to 2.2% in participants with type 2 diabetes, with 82% achieving target HbA1c below 6.5% Liver fat: More than 85% normalization in those with fatty liver disease Triglycerides: Significant reductions across all dose groups Blood pressure: Both systolic and diastolic improvements correlated with weight loss Waist circumference: Reductions averaging 10+ cm, indicating visceral fat loss The glycemic improvements are particularly notable given that glucagon raises blood sugar
The 4mg dose achieves weight loss comparable to Wegovy (15.2% vs 14.9%) with significantly lower diarrhea rates (18% vs 30%)
